A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The main goal of this study is to show that people with certain immune problems (from Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma) get fewer serious infections when they receive Gamunex C through an IV once every 4 weeks, along with their usual medical care, for one year. All participants will receive Gamunex-C 500 mg/kg once every 4 weeks (total 13 doses) starting Day 1 (Week 1) through Week 48 (end of Treatment Phase).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzona diagnoza przewlekłej białaczki limfocytowej (CLL) lub szpiczaka mnogiego (MM) lub chłoniaka nieziarniczego (NHL) typu B.
- •Niski poziom przeciwciał IgG (poniżej 5 g/L) w badaniu przesiewowym.
✗ Disqualifies
- •Przeszczep komórek macierzystych w ciągu ostatnich 6 miesięcy.
- •Przyjmowanie immunoglobulin lub podobnych terapii w ciągu ostatnich 6 miesięcy.
- •Aktywna infekcja lub aktywny inny nowotwór w momencie wizyty kwalifikującej.
- •Znana pierwotna niedoborowość odporności (PID).
- •Przewidywana długość życia krótsza niż 1,5 roku.
- •Poważne choroby, które mogą utrudnić ukończenie badania lub narazić pacjenta na ryzyko.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- October 1, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (5)
Study Site 102
St. Petersburg, United States
Study Site 101
Fort Wayne, United States
Study Site 105
Westbrook, United States
Study Site 104
Columbus, United States
Study Site 103
Tacoma, United States
Trial contact
Judith Wessels-Kranz
Marina Acosta Enslen
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/2/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.